Barrier integrity & mucosal repair

What actually decides this outcome, in order of size

Intestinal permeability is a genuine, quantifiable property of a membrane, and almost everything sold against it is judged by a test that does not measure it. Ranked by how much of the outcome each one owns:

1. Whether permeability was measured at all, and by what. The established method is a dual sugar absorption test: two probes are swallowed and their ratio is measured in urine, and the assay itself has been described and simplified in the literature Sequeira 2022. It is a timed urine collection, not a blood test, and almost nobody who believes they have a permeability problem has had one.
2. That the popular blood test is a different molecule. Human zonulin was identified as prehaptoglobin-2 Tripathi 2009, and the commercial assays used to measure it have been examined and found to misrepresent the field: the shortcomings of zonulin as a biomarker have been argued in print to be actively misleading intestinal permeability research Massier 2021. A serum zonulin result is not a permeability measurement.
3. Whether the barrier is the problem or the consequence. A permeable epithelium is produced by something: an infection, an inflammatory disease, a drug, alcohol, or a hard training block. A systematic review asking whether diet can alter intestinal barrier permeability in healthy people is the right place to calibrate expectations about how much of this is modifiable in the absence of a cause Nascimento 2024.
4. What happened to the one drug that did this directly, because it is the most informative fact on the page. Larazotide acetate is a zonulin antagonist that tightens intercellular junctions, and it was tested in celiac disease for persistent symptoms despite a gluten-free diet Leffler 2015. Its phase 3 interim analysis did not support continuation of the trial, and the public record of that is the sponsor's own announcement 9 Meters Biopharma Inc 2022 · announcement. The most rigorous attempt to treat a permeable barrier pharmacologically stopped at the last hurdle.
5. The supplements, last, and the best-evidenced one has a randomized trial in a defined population. Dietary glutamine supplements were tested in a randomized placebo-controlled trial in postinfectious irritable bowel syndrome Zhou 2019. That is a specific diagnosis after a specific event, which is exactly the kind of detail that gets dropped when the result is repeated as evidence for leaky gut in general.

The order to run these in, and what has to be true first

Find the cause, treat the cause, and measure the barrier only if the answer would change what you do. A permeability number with no plan attached to it is an expensive way to worry.

1. Exclude the diseases before buying a barrier product. Complete Blood Count (CBC) with Differential with Ferritin, hs-CRP (High-Sensitivity C-Reactive Protein) with ESR (Sed Rate), Comprehensive Metabolic Panel (CMP) for albumin, and celiac serology. Celiac disease is the condition in which the permeability story is best established and best treated, and it is diagnosed by a blood test and a biopsy rather than by a supplement.
2. Remove the causes that are already in the house. Alcohol, chronic non-steroidal use and very heavy training all increase measured permeability, and they are the reason the barrier is open in far more readers than any dietary factor is Nascimento 2024. Gut lining & mucosal repair is the page for that half of the problem.
3. Butyrate first among the purchasables, because the fuel argument is the best-established one. The microbiome and butyrate regulate energy metabolism and autophagy in the colonocyte Donohoe 2011, and microencapsulated sodium butyrate changes microbiota composition in inflammatory bowel disease patients Facchin 2020. Delivering it directly bypasses a fermenting microbiome you may not have.
4. L-Glutamine next, and cite the population it was trialed in. The randomized evidence is in postinfectious irritable bowel syndrome Zhou 2019. A reader whose symptoms started after a gastroenteritis is inside that trial; a reader with lifelong bloating is not, and should expect less.
5. Zinc Carnosine, Colostrum and Immunoglobulin (IgG) Concentrate are the adherent and luminal-binding tier. Each acts in the lumen or at the surface rather than systemically, which is a coherent place for a barrier agent to act and is also why none of them has a plasma level worth measuring.
6. Larazotide is the mechanism this whole page describes, and it is not on a shelf. It reached phase 3 in celiac disease Leffler 2015 and the interim analysis did not support continuing 9 Meters Biopharma Inc 2022 · announcement. Anybody selling a supplement on a zonulin-antagonist story is invoking a mechanism whose best clinical test is a negative one.
7. GLP-2 is trophic rather than sealing, and the distinction matters. It stimulates colonic growth through keratinocyte growth factor released by subepithelial myofibroblasts carrying GLP-2 receptors Orskov 2005. Growing mucosa and tightening junctions are two different repairs, and only one of them is what this page is named after.
8. Aloe Vera, Slippery Elm, Marshmallow Root, Probiotic, Gut Repair (EnteroMend), BPC-157 (inj/oral), KPV, DGL Licorice and Vitamin A are the remaining tiers. Oral aloe vera gel was tested in a randomized trial in active ulcerative colitis Langmead 2004, and whole-leaf extract is a different product with clear evidence of carcinogenic activity in a rodent bioassay Boudreau 2013. Probiotics have a critical appraisal of the evidence base worth reading before buying Koretz 2018. Vitamin A is required for mucosal differentiation and is the one item here with a genuine toxicity ceiling.

What gets bought for this that cannot move it

The category fails on its own biomarker, which is a rarer and more specific failure than being unproven. Serum zonulin is the number most often used to sell and to judge these products. Human zonulin is prehaptoglobin-2 Tripathi 2009, and the commercial assays' shortcomings have been argued to be actively blurring the picture in leaky gut research Massier 2021. A before-and-after zonulin is not weak evidence. It is evidence about a different analyte.

The strongest pharmacological version of this idea did not survive its phase 3 interim. Larazotide is the most literal tight-junction drug that has existed, developed by people who took the mechanism seriously enough to run celiac trials Leffler 2015, and the interim analysis did not support continuation 9 Meters Biopharma Inc 2022 · announcement. That is the honest ceiling on what tightening a barrier pharmacologically has been shown to deliver, and every supplement here sits below it.

Demulcents are the option on this page whose felt effect most exceeds its mechanism. A mucilage layer over irritated mucosa is mechanically sensible and symptomatically real, and there is no evidence it changes the underlying barrier. Relief and repair are separate endpoints here in the same way they are on a joint page, and conflating them is how somebody takes a coating agent for a year.

And if there is a cause, the cause is the page. A mucosa being actively injured by drugs, alcohol or heat belongs at Gut lining & mucosal repair. Distension on fermentable food belongs at Overgrowth, dysbiosis & antimicrobials. Stool form and colonic symptoms belong at Microbiome composition & prebiotic substrate. Systemic symptoms with a raised inflammatory marker belong with a clinician before they belong with a barrier supplement.

How you would know it was working, on a real read-out and a real timescale

The prediction is that if the barrier is the problem, a measured permeability ratio should fall while the exclusion panel stays normal. If the only thing that moved was a serum zonulin, nothing was measured Massier 2021. If nothing moved and the symptoms improved, the mechanism on this page was not the one that helped, which is still a useful result.

• A dual sugar absorption test, if you are going to measure permeability at all. It is a timed urine collection with two probes and a ratio Sequeira 2022, it has to be done the same way twice, and it is the only one of these that measures the quantity this page is named after. If it is not available to you, measure symptoms and skip the biomarker rather than substituting a worse one.
• hs-CRP (High-Sensitivity C-Reactive Protein) with ESR (Sed Rate) at baseline and 12 weeks. These are the systemic consequence a permeable barrier is supposed to produce, so a raised pair that falls is the closest thing to downstream confirmation available, and a normal pair at baseline means the systemic half of the story was never present in you.
• Complete Blood Count (CBC) with Differential with Ferritin and Comprehensive Metabolic Panel (CMP) at baseline. Anemia, iron deficiency and a low albumin are the findings that turn a barrier hypothesis into a diagnosis, and all three sit on two tubes.
• Vitamin A at 12 weeks if it is being supplemented. It is required for mucosal epithelial differentiation and secretory IgA, and it is fat-soluble with a real toxicity ceiling, which makes it the one item on this shelf where the read-out is as much about the upper bound as the lower one.
• Zinc, Plasma once. Zinc is a cofactor for the metalloproteinases and transcription factors involved in epithelial turnover, and it is the deficiency most likely to be present and unrecognized in somebody with longstanding gut symptoms.

What will fool you. A serum zonulin will move and it will mean nothing Tripathi 2009 Massier 2021. A dual sugar test is affected by renal function, by incomplete urine collection and by anything that changes transit, so a change without a matched protocol is a protocol change. Diet's measurable effect on barrier permeability in healthy people is smaller than the marketing implies Nascimento 2024. And any product bought on a zonulin-antagonist story is invoking a mechanism whose best-run clinical trial stopped at interim 9 Meters Biopharma Inc 2022 · announcement.

Sources read for these sections

• Massier L. Blurring the picture in leaky gut research: how shortcomings of zonulin as a biomarker mislead the field of intestinal permeability. Gut 2021;70(9):1801-1802 · PMID 33037053
• Tripathi A. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2.. Proc Natl Acad Sci U S A 2009 · PMID 19805376
• Leffler DA. Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial.. Gastroenterology 2015 · PMID 25683116
• 9 Meters Biopharma Inc. Interim Analysis of Phase 3 Study of Larazotide for Celiac Disease Does Not Support Trial Continuation.. Company announcement, 21 June 2022
• Sequeira IR. A Simple, Robust, and Convenient HPLC Assay for Urinary Lactulose and Mannitol in the Dual Sugar Absorption Test. Molecules 2022;27(9):2677 · PMID 35566024
• Nascimento DSMD. Can Diet Alter the Intestinal Barrier Permeability in Healthy People? A Systematic Review. Nutrients 2024;16(12):1871 · PMID 38931225
• Zhou Q, et al. Randomized placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome. Gut, 2019 · PMID 30108163
• Orskov C. GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors.. Regul Pept 2005 · PMID 15544847
• Donohoe DR, Garge N, Zhang X, et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metabolism 2011 · PMID 21531334
• Facchin S. Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease. Neurogastroenterol Motil 2020 · PMID 32476236
• Langmead L. Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis. Aliment Pharmacol Ther 2004 · PMID 15043514
• Boudreau MD. Clear evidence of carcinogenic activity by a whole-leaf extract of Aloe barbadensis miller (aloe vera) in F344/N rats. Toxicol Sci 2013 · PMID 22968693
• Koretz R. Probiotics in Gastroenterology: How Pro Is the Evidence in Adults?. The American Journal of Gastroenterology, 2018 · PMID 29915396